Dan Peizer Reveals Catalant’s Newest Acquisition

Sustainability

How is sustainability shifting from a reporting exercise to a design constraint in manufacturing and development?

Pharma's Almanac

Antibody Data

Does Antibody Development Have a Data Problem?

Sophie Lutter, Ph.D.

Lab Thread

Orthogonal Methods

Orthogonal Analytics: How Much Characterization Is Enough?

David Alvaro, Ph.D.

Pharma's Almanac

SmartScale

Phase-Appropriate CMC Requires a New Phase-Appropriate Manufacturing Model

Jesse McCool, Ph.D.

GBI Biomanufacturing

Data-Driven Mfg

Data-Driven Manufacturing and Digital Twins Across the Biologics Network

Jihyeon Oh; Hongwoo Joo

Samsung Biologics

ASDs

The Evolving Science of Amorphous Solid Dispersions

Pharma's Almanac

OpenAI Funding

OpenAI Foundation: The Why and How of Its Life Science Research Funding Agenda

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Liver Cancer

Overcoming Resistance in the New Era of Liver Cancer Immunotherapy

David Alvaro, Ph.D.

Pharma's Almanac

CLD

Can Mammalian Cell-Line Engineering Become a High-Throughput Design Problem?

Pharma's Almanac

Bioprocessing

Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Formulation Models

Predictive Formulation: Can Modeling Reduce Empirical Development?

David Alvaro, Ph.D.

Pharma's Almanac

LNP Analytics

Beyond Particle Size: Building a Complete Analytical Strategy for LNPs

Pharma's Almanac